Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeAnalog DevicesClinical-Grade AFE from Analog Devices Measures Four Vital Signs for Remote Patient...

Clinical-Grade AFE from Analog Devices Measures Four Vital Signs for Remote Patient Monitoring Devices

The MAX86178 Enables Synchronized Optical PPG and ECG Timing for Derived Health Metrics

Simplify the design of wearable remote patient monitoring (RPM) devices by measuring four vital signs with one MAX86178 triple-system vital signs analog front end (AFE) from Analog Devices, Inc.

This single-chip AFE integrates three measurement systems (optical, ECG and bio-impedance) to obtain four common vital signs: electrocardiogram (ECG or EKG), heart rate (ECG or optical PPG), blood-oxygen saturation (SpO2) and respiration rate (using BioZ). The MAX86178 enables synchronized optical PPG and ECG timing for derived health metrics.

  • View the MAX86178 triple-system vital signs AFE product page, download the datasheet and order samples: https://bit.ly/MAX86178_Product
  • Download a high-resolution image: https://bit.ly/Image_MAX86178
  • Connect with engineers and ADI product experts on EngineerZone™, an online technical support community: http://ez.analog.com

Medical device designers are eager to reduce annual healthcare-related expenditures by replacing office-based health monitoring systems with smaller, lower power, wireless devices worn discreetly and continuously in the home or office. With three clinical-grade subsystems integrated into one IC, the MAX86178 triple system AFE replaces discrete implementations by integrating an optical PPG sub-system to measure heart rate and SpO2, a single lead ECG sub-system, as well as a biopotential and bioimpedance (BioZ) sub-system to measure respiration rate. It permits small vital signs devices by fitting those multiple functions into a 2.6mm x 2.8mm package.

In addition, next-generation wearable RPMs need to operate at low power to permit smaller batteries or extend battery life to allow more convenient charging requirements. To enable ultra-low power features, the MAX86178 provides each subsystem with configurable options to optimize battery life for specific use cases.

“By integrating three healthcare subsystems on one piece of silicon, Analog Devices builds on its DNA and delivers this sensor-fusion product,” said Andrew Burt, Executive Business Manager of the Industrial and Healthcare Business Unit at Maxim Integrated®, now part of Analog Devices. “This AFE is resonating with the medical community because it presents new possibilities for chronic disease management, contagious disease diagnosis and remote monitoring. The MAX86178 enables small body-worn devices that can improve healthcare delivery and lower costs by keeping people out of the hospital.”

In addition, Analog Devices offers the MAX20343 buck-boost regulator and the MAX20360 power management IC as power solutions optimized for the MAX86178.

MAX86178 Triple-System Vital Signs AFE Features and Benefits

  • Small Size: Replaces medical facility grade monitoring systems with body-worn devices
  • Simplified Design: By integrating and synchronizing three different measurement systems to measure four vital signs, it simplifies design and enables even more complicated derivative vital signs monitoring

Availability

Product

Availability

Packaging

MAX86178

Now

2.6mm x 2.8mm WLP package 

MAX86178EVKIT#

Now

N/A

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy